Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian Tirado-Rives

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 3, 2005
Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptaseWilliam L Jorgensen, Juliana Ruiz-Caro, Julian Tirado-Rives, et al.
The Journal of Physical Chemistry. B|September 26, 2019
Absolute Free Energy of Binding Calculations for Macrophage Migration Inhibitory Factor in Complex with a Druglike InhibitorYue Qian, Israel Cabeza de Vaca, Jonah Z Vilseck, et al.
Journal of Chemical Information and Modeling|October 24, 2007
Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoringGabriela Barreiro, Cristiano R W Guimarães, Ivan Tubert-Brohman, et al.
Journal of Chemical Information and Modeling|April 21, 2009
Discovery of wild-type and Y181C mutant non-nucleoside HIV-1 reverse transcriptase inhibitors using virtual screening with multiple protein structuresSara E Nichols, Robert A Domaoal, Vinay V Thakur, et al.
Journal of Medicinal Chemistry|September 22, 2010
Synthesis and evaluation of selected key methyl ether derivatives of vancomycin aglyconChristine M Crane, Joshua G Pierce, Siegfried S F Leung, et al.
Journal of Medicinal Chemistry|October 17, 2012
Virtual screening and optimization yield low-nanomolar inhibitors of the tautomerase activity of Plasmodium falciparum macrophage migration inhibitory factorMarkus K Dahlgren, Alvaro Baeza Garcia, Alissa A Hare, et al.
ACS Catalysis|January 29, 2019
Molecular Dynamics Simulations of a Conformationally Mobile Peptide-Based Catalyst for Atroposelective BrominationXin Cindy Yan, Anthony J Metrano, Michael J Robertson, et al.
ACS Medicinal Chemistry Letters|December 21, 2017
Adding a Hydrogen Bond May Not Help: Naphthyridinone vs Quinoline Inhibitors of Macrophage Migration Inhibitory FactorThomas K Dawson, Pawel Dziedzic, Michael J Robertson, et al.
Journal of Medicinal Chemistry|June 28, 2002
Prediction of activity for nonnucleoside inhibitors with HIV-1 reverse transcriptase based on Monte Carlo simulationsRobert C Rizzo, Marina Udier-Blagović, De-Ping Wang, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2008
Energetic effects for observed and unobserved HIV-1 reverse transcriptase mutations of residues L100, V106, and Y181 in the presence of nevirapine and efavirenzMarilyn B Kroeger Smith, Lenea H Rader, Amanda M Franklin, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|November 3, 2005
Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptaseWilliam L Jorgensen, Juliana Ruiz-Caro, Julian Tirado-Rives, et al.
The Journal of Physical Chemistry. B|September 26, 2019
Absolute Free Energy of Binding Calculations for Macrophage Migration Inhibitory Factor in Complex with a Druglike InhibitorYue Qian, Israel Cabeza de Vaca, Jonah Z Vilseck, et al.
Journal of Chemical Information and Modeling|October 24, 2007
Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoringGabriela Barreiro, Cristiano R W Guimarães, Ivan Tubert-Brohman, et al.
Journal of Chemical Information and Modeling|April 21, 2009
Discovery of wild-type and Y181C mutant non-nucleoside HIV-1 reverse transcriptase inhibitors using virtual screening with multiple protein structuresSara E Nichols, Robert A Domaoal, Vinay V Thakur, et al.
Journal of Medicinal Chemistry|September 22, 2010
Synthesis and evaluation of selected key methyl ether derivatives of vancomycin aglyconChristine M Crane, Joshua G Pierce, Siegfried S F Leung, et al.
Journal of Medicinal Chemistry|October 17, 2012
Virtual screening and optimization yield low-nanomolar inhibitors of the tautomerase activity of Plasmodium falciparum macrophage migration inhibitory factorMarkus K Dahlgren, Alvaro Baeza Garcia, Alissa A Hare, et al.
ACS Catalysis|January 29, 2019
Molecular Dynamics Simulations of a Conformationally Mobile Peptide-Based Catalyst for Atroposelective BrominationXin Cindy Yan, Anthony J Metrano, Michael J Robertson, et al.
ACS Medicinal Chemistry Letters|December 21, 2017
Adding a Hydrogen Bond May Not Help: Naphthyridinone vs Quinoline Inhibitors of Macrophage Migration Inhibitory FactorThomas K Dawson, Pawel Dziedzic, Michael J Robertson, et al.
Journal of Medicinal Chemistry|June 28, 2002
Prediction of activity for nonnucleoside inhibitors with HIV-1 reverse transcriptase based on Monte Carlo simulationsRobert C Rizzo, Marina Udier-Blagović, De-Ping Wang, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2008
Energetic effects for observed and unobserved HIV-1 reverse transcriptase mutations of residues L100, V106, and Y181 in the presence of nevirapine and efavirenzMarilyn B Kroeger Smith, Lenea H Rader, Amanda M Franklin, et al.
Pageof 7